Three specific biomarkers provide accurate indication of severity of Chikungunya fever, emerging as threat in South-East Asia, Pacific and Europe, according to research conducted in Singapore. Since biomarkers can be easily detected and measured in blood, this finding could expedite patient identification and monitoring.